DLH

Digital Infuzion Welcomes Dr. Davyd Chung as Chief Growth Officer to Spearhead Strategic Expansion

Retrieved on: 
Monday, May 6, 2024

ROCKVILLE, Md., May 6, 2024 /PRNewswire-PRWeb/ -- Joining the team on April 8, Dr. Davyd Chung brings over two decades of distinguished expertise in strategic growth and business development within the health sector.

Key Points: 
  • Digital Infuzion, a leader in health information technology solutions, is thrilled to announce the appointment of Dr. Davyd Chung as its new Chief Growth Officer.
  • Digital Infuzion is confident that Dr. Chung's strategic insights and leadership will propel the company towards new horizons of success and innovation in the health IT sector.
  • ROCKVILLE, Md., May 6, 2024 /PRNewswire-PRWeb/ -- Joining the team on April 8, Dr. Davyd Chung brings over two decades of distinguished expertise in strategic growth and business development within the health sector.
  • "Davyd's background in biomedical research and his proven track record in strategic growth are tremendous assets to us," said Hemant Virkar, CEO of Digital Infuzion.

DLH to Announce Fiscal 2024 Second Quarter Financial Results

Retrieved on: 
Monday, April 22, 2024

ATLANTA, April 22, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and human services provider to the federal government, will release financial results for the fiscal second quarter ended March 31, 2024 on May 1, 2024 after the market closes.

Key Points: 
  • ATLANTA, April 22, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and human services provider to the federal government, will release financial results for the fiscal second quarter ended March 31, 2024 on May 1, 2024 after the market closes.
  • DLH will then host a conference call for the investment community at 10:00 a.m. Eastern Time the following day, May 2, 2024, during which members of senior management will make a brief presentation focused on the financial results and operating trends.
  • Interested parties may listen to the conference call by dialing 888-347-5290 or 412-317-5256.
  • Presentation materials will also be posted on the Investor Relations section of the DLH website prior to the commencement of the conference call.

DLH to Provide Information Technology Services to the National Cancer Institute

Retrieved on: 
Thursday, March 7, 2024

NCI, the largest institute under NIH, is the federal government's principal agency for cancer research, training, and health information dissemination.

Key Points: 
  • NCI, the largest institute under NIH, is the federal government's principal agency for cancer research, training, and health information dissemination.
  • “This new award extends DLH’s longstanding partnership with NCI’s Center for Biomedical Informatics and Information Technology (“CBIIT”) by providing scientific computing and informatics to support NCI’s research mission,” said Zach Parker, President and Chief Executive Officer of DLH.
  • The contract was competitively awarded through the multiple-award blanket purchase agreement with CBIIT that the Company announced in February 2023.
  • Through this work, DLH will provide IT services for nearly 7,000 NCI employees, on matters ranging from hardware configuration to software management strategies, ServiceNow functions, network connectivity, desktop data protection, desktop platform engineering, technology refresh, and more.

DLH to Provide Information Technology Services at National Institute on Drug Abuse

Retrieved on: 
Tuesday, February 13, 2024

ATLANTA, Feb. 13, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading Health IT provider of digital transformation and cybersecurity, science research and development, and systems engineering and integration, today announced that it has been awarded a contract to continue providing information technology services for the National Institutes of Health’s (“NIH”) National Institute on Drug Abuse (“NIDA”).

Key Points: 
  • ATLANTA, Feb. 13, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading Health IT provider of digital transformation and cybersecurity, science research and development, and systems engineering and integration, today announced that it has been awarded a contract to continue providing information technology services for the National Institutes of Health’s (“NIH”) National Institute on Drug Abuse (“NIDA”).
  • NIDA is the lead federal agency supporting scientific research on drug use and addiction.
  • Through this award, DLH will provide a host of information technology services for NIDA, including managing the operations of an integrated advanced clinical/research informatics series of systems which enables researchers to share data and resources in real time.
  • “That NIDA continues to choose DLH for this important work is a testament to our team’s superb execution and commitment to excellence.”

AM Best Affirms Credit Ratings of The Dai-ichi Life Insurance Company, Limited

Retrieved on: 
Friday, February 9, 2024

Dai-ichi Life, Dai-ichi Frontier Life Insurance Co., Ltd., and The Neo First Life Insurance Company, Limited) to meet customer needs across different segments.

Key Points: 
  • Dai-ichi Life, Dai-ichi Frontier Life Insurance Co., Ltd., and The Neo First Life Insurance Company, Limited) to meet customer needs across different segments.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings .
  • For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments .
  • AM Best is a global credit rating agency, news publisher and data analytics provider specialising in the insurance industry.

DLH Reports Fiscal 2024 First Quarter Results

Retrieved on: 
Wednesday, January 31, 2024

First quarter revenue was $97.9 million in fiscal 2024 versus $72.7 million in fiscal 2023, reflecting the impact from the Company's December 2022 acquisition.

Key Points: 
  • First quarter revenue was $97.9 million in fiscal 2024 versus $72.7 million in fiscal 2023, reflecting the impact from the Company's December 2022 acquisition.
  • Earnings were $2.2 million, or $0.15 per diluted share, for the fiscal 2024 first quarter versus $1.5 million, or $0.11 per diluted share, for the first quarter of fiscal 2023, reflecting higher income from operations offset by increased interest expense
    Earnings before interest, taxes, depreciation and amortization ("EBITDA") were $11.1 million for the fiscal 2024 first quarter as compared to $6.3 million in the fiscal 2023 first quarter.
  • Results for the Three Months Ended December 31, 2023
    Revenue for the first quarter of fiscal 2024 was $97.9 million versus $72.7 million in fiscal 2023, with the year-over-year increase largely from the December 2022 acquisition.
  • The Company reported net income of approximately $2.2 million, or $0.15 per diluted share, for the first quarter of fiscal 2024 versus $1.5 million, or $0.11 per diluted share, for the first quarter of fiscal 2023.

Industry-Recognized Technology Leader Joins DLH as Strategic Advisor

Retrieved on: 
Tuesday, January 23, 2024

Ms. Carmody previously served as Chief Information Officer at SAIC and Jacobs Engineering, both industry leading information technology solutions providers.

Key Points: 
  • Ms. Carmody previously served as Chief Information Officer at SAIC and Jacobs Engineering, both industry leading information technology solutions providers.
  • She has extensive experience in emerging technology applications, risk assessments and management, and governance, and has worked throughout her career to integrate technology solutions to solve complex challenges.
  • “We are delighted to engage an industry-recognized technology leader such as Cora as a strategic advisor to DLH,” stated Zach Parker, DLH President and CEO.
  • “We believe Cora’s deep understanding of technology applicable to DLH’s missions in health and cyber, combined with her passion for growth and innovation, will be of great value to DLH.”

DLH to Announce Fiscal 2024 First Quarter Financial Results

Retrieved on: 
Monday, January 22, 2024

ATLANTA, Jan. 22, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and human services provider to the federal government, will release financial results for the fiscal first quarter ended December 31, 2023 on January 31, 2024 after the market closes.

Key Points: 
  • ATLANTA, Jan. 22, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and human services provider to the federal government, will release financial results for the fiscal first quarter ended December 31, 2023 on January 31, 2024 after the market closes.
  • DLH will then host a conference call for the investment community at 10:00 a.m. Eastern Time the following day, February 1, 2024, during which members of senior management will make a brief presentation focused on the financial results and operating trends.
  • Interested parties may listen to the conference call by dialing 888-347-5290 or 412-317-5256.
  • Presentation materials will also be posted on the Investor Relations section of the DLH website prior to the commencement of the conference call.

DLH Reports Fiscal 2023 Fourth Quarter Results

Retrieved on: 
Wednesday, December 6, 2023

Fourth quarter revenue was $101.5 million in fiscal 2023 versus $67.2 million in fiscal 2022, primarily reflecting the impact from the Company's December 2022 acquisition as well as net organic growth in the business.

Key Points: 
  • Fourth quarter revenue was $101.5 million in fiscal 2023 versus $67.2 million in fiscal 2022, primarily reflecting the impact from the Company's December 2022 acquisition as well as net organic growth in the business.
  • Reflecting the previously announced non-cash impairment charge of $7.7 million, earnings were $(2.6) million, or $(0.18) per diluted share, for the fiscal 2023 fourth quarter versus $3.4 million, or $0.24 per diluted share, for the fourth quarter of fiscal 2022.
  • Earnings before interest, taxes, depreciation and amortization ("EBITDA") were $4.4 million for the fiscal 2023 fourth quarter as compared to $6.6 million in the fiscal 2022 fourth quarter.
  • The Company reported net (loss)/income of approximately $(2.6) million, or $(0.18) per diluted share, for the fourth quarter of fiscal 2023 versus $3.4 million, or $0.24 per diluted share, for the fourth quarter of fiscal 2022.

DLH to Announce Fiscal 2023 Fourth Quarter Financial Results

Retrieved on: 
Monday, November 27, 2023

ATLANTA, Nov. 27, 2023 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and human services provider to the federal government, will release financial results for its fiscal fourth quarter ended September 30, 2023 on December 6, 2023 after the market closes.

Key Points: 
  • ATLANTA, Nov. 27, 2023 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and human services provider to the federal government, will release financial results for its fiscal fourth quarter ended September 30, 2023 on December 6, 2023 after the market closes.
  • DLH will then host a conference call for the investment community at 10:00 a.m. Eastern Time the following day, December 7, 2023, during which members of senior management will make a brief presentation focused on the financial results and operating trends.
  • Interested parties may listen to the conference call by dialing 888-347-5290 or 412-317-5256.
  • Presentation materials will also be posted on the Investor Relations section of the DLH website prior to the commencement of the conference call.